Our findings suggest that AFAP1-AS1 functions as an oncogenic biomarker and promotes NPC tumorigenicity through enhanced KAT2B acetyltransferase activation and YAP mRNA stabilization. The gene discussed is AFAP1; the disease is nasopharyngeal carcinoma.